Notoginsenoside R1 Attenuates Cisplatin-Induced Ototoxicity by Inducing Heme Oxygenase-1 Expression and Suppressing Oxidative Stress

被引:0
|
作者
Lin, Yi-Chun [1 ]
Ho, Yi-Jung [2 ,3 ]
Lin, Yuan-Yung [1 ]
Liao, Ai-Ho [4 ]
Kuo, Chao-Yin [1 ]
Chen, Hang-Kang [1 ]
Chen, Hsin-Chien [1 ]
Wang, Chih-Hung [1 ,5 ]
Shih, Cheng-Ping [1 ]
机构
[1] Triserv Gen Hosp, Natl Def Med Ctr, Dept Otolaryngol Head & Neck Surg, Taipei 11490, Taiwan
[2] Natl Def Med Ctr, Sch Pharm, Taipei 11490, Taiwan
[3] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 11490, Taiwan
[4] Natl Taiwan Univ Sci & Technol, Grad Inst Biomed Engn, Taipei 10607, Taiwan
[5] Taipei City Hosp, Dept Ophthalmol, Taipei, 103212, Taiwan
关键词
cisplatin; cochlea; hair cells; notoginsenoside; ototoxicity; oxidative stress; PANAX-NOTOGINSENG; INDUCED NEPHROTOXICITY; SODIUM THIOSULFATE; CELLS; PREVENTION; PROTECTS; PATHWAY;
D O I
10.3390/ijms252111444
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cisplatin-induced ototoxicity occurs in approximately half of patients treated with cisplatin, and pediatric patients are more likely to be affected than adults. The oxidative stress elicited by cisplatin is a key contributor to the pathogenesis of ototoxicity. Notoginsenoside R1 (NGR1), the main bioactive compound of Panax notoginseng saponins, has antioxidant and antiapoptotic effects. This study investigated the ability of NGR1 to protect against cisplatin-induced damage in auditory HEI-OC1 cells and neonatal murine cochlear explants. The viability of HEI-OC1 cells treated with NGR1 and cisplatin was greater than that of cells treated with cisplatin alone. The results of Western blots and immunostaining for cleaved caspase-3 revealed that the level of cleaved caspase-3 in the cells treated with cisplatin was repressed by NGR1. NGR1 attenuated cisplatin-induced cytotoxicity in HEI-OC1 cells. Intracellular reactive oxygen species (ROS) were detected with a DCFDA assay and immunostaining for 4-HNE. The result revealed that its expression was induced by cisplatin and was significantly reduced by NGR1. Moreover, NGR1 can promote heme oxygenase-1 (HO-1) expression at both the mRNA and protein levels. ZNPPIX, an HO-1 inhibitor, was administered to cisplatin-treated cells to investigate the role of HO-1 in the protective effect of NGR1. The suppression of HO-1 activity by ZNPPIX markedly abolished the protective effect of NGR1 on cisplatin-treated cells. Therefore, NGR1 protects cells from cisplatin-induced damage by activating HO-1 and its antioxidative activity. In cochlear explants, NGR1 protects cochlear hair cells and attenuates cisplatin-induced ototoxicity by inhibiting ROS generation. In the group treated with cisplatin alone, prominent loss of outer hair cells and severe damage to the structure of the stereociliary bundles of inner and outer hair cells were observed. Compared with the group treated with cisplatin alone, less loss of outer hair cells (p = 0.009) and better preservation of the stereociliary bundles of hair cells were observed in the group treated with cisplatin and NGR1. In conclusion, these findings indicate that NGR1 can protect against cisplatin-induced ototoxicity by inducing HO-1 expression and suppressing oxidative stress.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Complementary regulation of heme oxygenase-1 and peroxiredoxin I gene expression by oxidative stress in the liver
    Immenschuh, S
    Fahimi, HD
    Baumgart-Vogt, E
    CELLULAR AND MOLECULAR BIOLOGY, 2005, 51 (05) : 471 - 477
  • [32] Heme oxygenase-1 attenuates seawater drowning-induced acute lung injury through a reduction in inflammation and oxidative stress
    Sun, Xue-qian
    Wu, Chen
    Qiu, Yu-bao
    Wu, Ya-Xian
    Chen, Jun-liang
    Huang, Jian-feng
    Chen, Dan
    Pang, Qing-feng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 74
  • [33] Heme oxygenase-1 expression and its relation to oxidative stress during primary culture of cardiomyocytes
    Hoshida, S
    Nishida, M
    Yamashita, N
    Igarashi, J
    Aoki, K
    Hori, M
    Kuzuya, T
    Tada, M
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1996, 28 (09) : 1845 - 1855
  • [34] Octreotide attenuates liver fibrosis by inhibiting hepatic heme oxygenase-1 expression
    Guo, Shi-Bin
    Li, Qing
    Duan, Zhi-Jun
    Wang, Qiu-Ming
    Zhou, Qin
    Sun, Xiao-Yu
    MOLECULAR MEDICINE REPORTS, 2015, 11 (01) : 83 - 90
  • [35] Impairment of oxidative stress-induced heme oxygenase-1 expression by the defect of Parkinson-related gene of PINK1
    Chien, Wei-Lin
    Lee, Tzeng-Ruei
    Hung, Shih-Ya
    Kang, Kai-Hsiang
    Lee, Ming-Jen
    Fu, Wen-Mei
    JOURNAL OF NEUROCHEMISTRY, 2011, 117 (04) : 643 - 653
  • [36] Astrocyte-specific heme oxygenase-1 hyperexpression attenuates heme-mediated oxidative injury
    Benvenisti-Zarom, Luna
    Regan, Raymond F.
    NEUROBIOLOGY OF DISEASE, 2007, 26 (03) : 688 - 695
  • [37] Atorvastatin inhibits Lipopolysaccharide (LPS)-induced vascular inflammation to protect endothelium by inducing Heme Oxygenase-1 (HO-1) expression
    Luo, Jian
    Zhu, Qian
    Huang, Keming
    Wen, Xue
    Peng, Yongquan
    Chen, Gong
    Wei, Gang
    PLOS ONE, 2024, 19 (08):
  • [38] Induction of heme oxygenase-1 with hemin alleviates cisplatin-induced reproductive toxicity in male rats and enhances its cytotoxicity in prostate cancer cell line
    Heeba, Gehan Hussein
    Hamza, Alaaeldin Ahmed
    Hassanin, Soha Osama
    TOXICOLOGY LETTERS, 2016, 264 : 38 - 50
  • [39] Notoginsenoside R1 induces oxidative stress and modulates LPS induced immune microenvironment of nasopharyngeal carcinoma
    Li, Siwei
    Pi, Guoliang
    Zeng, Yong
    Ruan, Changli
    He, Xiaosong
    Xiong, Xiaoxia
    Zhang, Man
    Zou, Jiahua
    Liang, Xinjun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [40] Protocatechuic Aldehyde Attenuates Cisplatin-Induced Acute Kidney Injury by Suppressing Nox-Mediated Oxidative Stress and Renal Inflammation
    Gao, Li
    Wu, Wei-Feng
    Dong, Lei
    Ren, Gui-Ling
    Li, Hai-Di
    Yang, Qin
    Li, Xiao-Feng
    Xu, Tao
    Li, Zeng
    Wu, Bao-Ming
    Ma, Tao-Tao
    Huang, Cheng
    Huang, Yan
    Zhang, Lei
    Lv, Xiongwen
    Li, Jun
    Meng, Xiao-Ming
    FRONTIERS IN PHARMACOLOGY, 2016, 7